AXL and colorectal cancer: Consistent with the role of AXL in promoting EMT in cancer, targeting AXL by selective inhibitors, germline knockout, RNAi, and inactivating mAbs prevented etastasis of various epithelial tumours, including but not limited to, breast, lung, ovarian, and colorectal cancers.